Neuro-oncology

MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib.

Neuro-oncology

Chahal M, Xu Y, Lesniak D, Graham K, Famulski K, Christensen JG, Aghi M, Jacques A, Murray D, Sabri S, Abdulkarim B

TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients.

Neuro-oncology

Crane CA, Han SJ, Barry JJ, Ahn BJ, Lanier LL, Parsa AT

TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients.

Neuro-oncology

Crane CA, Han SJ, Barry JJ, Ahn BJ, Lanier LL, Parsa AT

Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific.

Neuro-oncology

Jun P, Hong C, Lal A, Wong JM, McDermott MW, Bollen AW, Plass C, Held WA, Smiraglia DJ, Costello JF

Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific.

Neuro-oncology

Jun P, Hong C, Lal A, Wong JM, McDermott MW, Bollen AW, Plass C, Held WA, Smiraglia DJ, Costello JF

Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM.

Neuro-oncology

Du R, Petritsch C, Lu K, Liu P, Haller A, Ganss R, Song H, Vandenberg S, Bergers G

Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM.

Neuro-oncology

Du R, Petritsch C, Lu K, Liu P, Haller A, Ganss R, Song H, Vandenberg S, Bergers G

Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype.

Neuro-oncology

Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, Berger MS

Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype.

Neuro-oncology

Lim DA, Cha S, Mayo MC, Chen MH, Keles E, VandenBerg S, Berger MS

Pages